• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Anti-Diabetic and weight loss effect of Sleeve gastrectomy and Sleeve Bypass in Japanese morbid obese patients, introduction of bariatric surgery in Japanese Hospital

Anti-Diabetic and weight loss effect of Sleeve gastrectomy and Sleeve Bypass in Japanese morbid obese patients, introduction of bariatric surgery in Japanese Hospital

Takeshi Naitoh, MD, FACS, T Miyachi, MD, H Imoto, MD, N Tanaka, MD, T Morikawa, MD, M Kakyo, MD, M Nagao, MD, S Haneda, MD, S Ohnuma, MD, H Sasaki, MD, K Kudo, MD, T Okada, MD, H Hayashi, MD, H Yoshida, MD, F Motoi, MD, Y Katayose, MD, K Miura, MD, C Shibata, MD, M Unno, MD

Department of Surgery, Tohoku University Hospital

[Backgrounds] A percentage of Japanese obese patients whose BMI is over 30 is approximately 3%, which is still quite low compared with western countries. Therefore, a bariatric surgery had been uncommon surgical option for the treatment of morbidly obese patients in Japan until recently. Only a few private hospitals and University hospitals have been performing the bariatric surgery in Japan. Total number of cases of bariatric surgery in Japan is still around 600. However, due to recent change of dietary habit, a population of obese patients has been increasing rapidly as well as in western countries. Moreover, in Japanese obese patients, type 2 diabetes (T2DM) tends to become severe with a relatively low BMI. We recently introduced a bariatric surgery for morbid obese patients. Since a rate of gastric cancer is thought to be high, we started from sleeve gastrectomy instead of roux-en Y gastric bypass which is most common procedure in the United States. Then we introduced sleeve gastrectomy with duodeno-jejunal bypass. Here, we present early results of our cases.

[Patients and Methods] Since October 2010, we have performed 13 bariatric surgery laparoscpically. Indication of surgery is patients’ BMI>35-kg/m2, or BMI>32-kg/m2 with severe T2DM, which is considered as a metabolic surgery. Eight patients underwent Laparoscopic Sleeve Gastrectomy (LSG), and 5 patients underwent Laparoscopic Sleeve gastrectomy with Duodeno-jejunal bypass (LSG/DJB). Meal Tolerance Test (MTT) was performed at preop, 3 month, 6month, and 12 month postoperatively. Of those patients, we assessed perioperative outcomes, short term weight loss effect and anti-diabetic effect. [Results] Mean age of patients is 43-y.o. BMI is 45kg/m2 in average (LSG: 49, LSG/DJB: 38). Nine of 13 cases are in medical treatment for T2DM (LSG: 4/8, LSG/DJB: 5/5). Mean preop HbA1C level (NGSP) is 6.2% in LSG, 8.1% in LSG/DJB. Preop HOMA-IR is 4.7 in LSG, and 4.6 in LSG/DJB. Operative time was 142min in LSG, and 270min in LSG/DJB. Estimated blood loss was 13g in LSG and 75g in LSG/DJB, respectively. No postoperative complication or mortality was observed. EBWL% after 6 month was 39.2% in LSG, and 51.5% in LSG/DJB. HOMA-IR 6 month after surgery decreased to 2.0 in both groups. Only one patient in LSG/DJB requires postoperative medical treatment for T2DM, who previously received over 70IU of Insulin injection with preop serum C-peptide level of 1.2ng/ml, while other patients does not take any anti-diabetic medicine after surgery. MTT shows dramatic improvement of blood glucose curve and IRI curve.

[Conclusion] We have successfully introduced bariatric surgery in our hospital. Both LSG and LSG/DJB have good effect on both weight loss and T2DM. Even severe diabetes can be improved with LSG/DJB. These results support to spread the bariatric surgery in our country.


Session: Poster Presentation

Program Number: P417

189

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals